ArticleInternal medicine (Tokyo, Japan)2021

Reply to "Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?"

Hiroaki Matsuura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.